肺淋巴管平滑肌瘤病1例并文獻(xiàn)復(fù)習(xí)
本文關(guān)鍵詞:肺淋巴管平滑肌瘤病1例并文獻(xiàn)復(fù)習(xí) 出處:《中醫(yī)藥臨床雜志》2017年04期 論文類型:期刊論文
更多相關(guān)文章: 肺淋巴管平滑肌瘤病 病例報(bào)道 研究進(jìn)展
【摘要】:目的:探討肺淋巴管平滑肌瘤病(PLAM)的病理與臨床表現(xiàn)、影像學(xué)特征、診斷和治療,提高對該病的認(rèn)識(shí),減少誤診及漏診。方法:回顧性分析1例我院臨床確診的PLAM患者病歷資料,并復(fù)習(xí)相關(guān)文獻(xiàn)。結(jié)果:本病主要發(fā)生于育齡期婦女,亦可發(fā)生于絕經(jīng)后,本例PLAM患者發(fā)病于絕經(jīng)后1年。PLAM肺部表現(xiàn)有活動(dòng)后呼吸困難、咯血、反復(fù)發(fā)作的性氣胸、乳糜胸等,肺外表現(xiàn)有乳糜腹、腎血管平滑肌脂瘤、子宮肌瘤、顱內(nèi)病變等。HRCT的典型表現(xiàn)為雙肺彌漫分布的薄壁囊狀影。肺功能以阻塞性或混合性通氣功能障礙為主。病理檢查為確診金標(biāo)準(zhǔn)。黑色素瘤相關(guān)的HMB45抗體絕大多數(shù)為陽性。血管內(nèi)皮生長因子D(VEGF-D)有很高的敏感性和特異性,診斷該病有潛在價(jià)值。結(jié)論:目前本病病因尚不清,針對TSC1/TSC2基因突變的靶向藥物雷帕霉素能改善部分患者癥狀及肺功能,具有一定療效。
[Abstract]:Objective: To investigate the pathological and clinical manifestations, imaging features, diagnosis and treatment of pulmonary lymphatic leiomyomias (PLAM), and to improve the understanding of the disease and reduce misdiagnosis and missed diagnosis. Methods: a retrospective analysis of 1 cases of clinical records of PLAM patients in our hospital was reviewed, and the related literature was reviewed. Results: this disease mainly occurred in women of childbearing age, and could also occur after menopause. This case of PLAM patients occurred 1 years after menopause. PLAM manifestations of exertional dyspnea, hemoptysis, recurrent pneumothorax, chylothorax, lung manifestations of chyloperitoneum, renal vascular smooth muscle lipoma, uterine fibroids, intracranial lesions. The typical manifestation of HRCT is thin-walled cystic shadow in the diffuse distribution of two lungs. Pulmonary function is mainly obstructed or mixed ventilation dysfunction. The pathological examination was the standard of the diagnosis of gold. Most of the HMB45 antibodies associated with melanoma were positive. Vascular endothelial growth factor D (VEGF-D) has a high sensitivity and specificity, and it is of potential value in the diagnosis of this disease. Conclusion: the etiology of this disease is unclear, the mutation of TSC1/TSC2 gene targeted drug rapamycin can improve symptoms and pulmonary function, have certain curative effect.
【作者單位】: 安徽中醫(yī)藥大學(xué);安徽省中醫(yī)院;
【基金】:國家中醫(yī)藥管理局“十二五”重點(diǎn)學(xué)科-中醫(yī)老年病資助項(xiàng)目(NO 2012-170)
【分類號】:R734.2
【正文快照】: Pulmonary Lymphangiomyomatosis(One Case and Review of the Literature)HUANG He1,GONG Qiang-jing2,ZHANG Nian-zhi21.Anhui University of traditional Chinese Medicine,230038,China2.Anhui Chinese Medicine Hospital,230031,ChinaOne case of Pulmonary Lymphangiomy
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 劉堅(jiān);以肺外表現(xiàn)為首發(fā)癥狀的肺癌11例誤診分析[J];中國實(shí)用內(nèi)科雜志;2000年11期
2 武廣麗;肺癌首發(fā)肺外表現(xiàn)臨床分析[J];安徽醫(yī)學(xué);2000年06期
3 肖寶紅,張建軍;肺癌首發(fā)肺外表現(xiàn)19例[J];中原醫(yī)刊;2000年02期
4 李群彥;肺癌的肺外表現(xiàn)2例[J];現(xiàn)代中西醫(yī)結(jié)合雜志;2000年07期
5 李紅雯;老年人首發(fā)肺外表現(xiàn)型肺癌2例[J];人民軍醫(yī);2002年04期
6 馮先富,陸林;肺癌患者肺外表現(xiàn)11例報(bào)告[J];山東醫(yī)藥;1985年01期
7 李國順;;肺癌的肺外表現(xiàn)(附22例分析)[J];山西醫(yī)藥雜志;1992年03期
8 陶慎芳,居乃暢;19例肺癌首發(fā)肺外表現(xiàn)的分析[J];安徽醫(yī)科大學(xué)學(xué)報(bào);1993年04期
9 姜濤,修青;首發(fā)肺外表現(xiàn)的肺癌46例臨床分析[J];臨床醫(yī)學(xué);1997年09期
10 鄭國豪,王勇民;肺癌首發(fā)肺外表現(xiàn)17例臨床分析[J];咸寧醫(yī)學(xué)院學(xué)報(bào);2000年04期
相關(guān)重要報(bào)紙文章 前3條
1 徐州醫(yī)學(xué)院第二附屬醫(yī)院 杜長明;警惕肺癌的肺外表現(xiàn)[N];大眾衛(wèi)生報(bào);2002年
2 本報(bào)記者 楊怡;警惕肺癌的“肺外表現(xiàn)”[N];樂山日報(bào);2007年
3 中南大學(xué)湘雅醫(yī)院 何爭鳴;皮膚長紅斑 肺癌在作怪[N];大眾衛(wèi)生報(bào);2003年
,本文編號:1340004
本文鏈接:http://sikaile.net/zhongyixuelunwen/1340004.html